Immunicom Presents Promising Clinical Trial Data at AACR in Late-Stage Breast Cancer Patients Treated with Novel Non-Pharmaceutical Immunotherapy
Signals new era for cancer treatment SAN DIEGO--(BUSINESS WIRE)--#biotech--Immunicom, Inc., a global biotech company that is redefining immuno-oncology with breakthrough...